317 related articles for article (PubMed ID: 18806522)
41. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
[TBL] [Abstract][Full Text] [Related]
42. Outpatient use of cardiovascular drugs during pregnancy.
Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
[TBL] [Abstract][Full Text] [Related]
43. [Medical therapy in revascularized coronary artery disease patients].
Liu XH; DU X; Kang JP; Lü Q; Zhang Q; Lü SZ; Chen F; Ma CS
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):236-9. PubMed ID: 18361833
[TBL] [Abstract][Full Text] [Related]
44. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow.
Sen N; Ozlü MF; Başar N; Ozcan F; Güngör O; Turak O; Malçok O; Cağli K; Maden O; Erbay AR; Demir AD
Turk Kardiyol Dern Ars; 2009 Apr; 37(3):168-73. PubMed ID: 19553739
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
[TBL] [Abstract][Full Text] [Related]
46. Prevention and management of coronary artery disease in patients with diabetes mellitus.
Majid A
Acta Med Indones; 2009 Jan; 41(1):41-4. PubMed ID: 19258681
[TBL] [Abstract][Full Text] [Related]
47. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
48. Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.
Roughead EE; Vitry AI; Preiss AK; Barratt JD; Gilbert AL; Ryan P
Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):71-6. PubMed ID: 19587601
[TBL] [Abstract][Full Text] [Related]
49. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home.
Ghosh S; Ziesmer V; Aronow WS
J Gerontol A Biol Sci Med Sci; 2002 Jun; 57(6):M398-400. PubMed ID: 12023270
[TBL] [Abstract][Full Text] [Related]
50. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
Filion KB; Pilote L; Rahme E; Eisenberg MJ
J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
[TBL] [Abstract][Full Text] [Related]
51. Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis.
Szperl M; Dzielinska Z; Roszczynko M; Malek LA; Makowiecka-Ciesla M; Demkow M; Kadziela J; Prejbisz A; Florczak E; Zielinski T; Januszewicz A; Ruzyllo W
Med Sci Monit; 2008 Dec; 14(12):CR611-6. PubMed ID: 19043368
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic approach in patients with stable angina.
Lettino M; Falcone C; Tavazzi L
Ital Heart J; 2005 Jan; 6(1):1-8. PubMed ID: 15773267
[TBL] [Abstract][Full Text] [Related]
53. Potential oral manifestations of cardiovascular drugs.
Habbab KM; Moles DR; Porter SR
Oral Dis; 2010 Nov; 16(8):769-73. PubMed ID: 20604876
[TBL] [Abstract][Full Text] [Related]
54. Calcium channels blockers and progression of kidney disease.
Ziakka S; Kaperonis N; Ferentinou E; Karakasis F; Ntatsis G; Kourvelou C; Papagalanis N
Ren Fail; 2007; 29(8):1003-12. PubMed ID: 18067048
[TBL] [Abstract][Full Text] [Related]
55. The importance of diabetes as a cardiovascular risk factor.
Plouin PF
Int J Clin Pract Suppl; 2000 May; (110):3-8. PubMed ID: 10912301
[No Abstract] [Full Text] [Related]
56. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
[TBL] [Abstract][Full Text] [Related]
57. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
58. C-reactive protein (CRP)-lowering agents.
Prasad K
Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
[TBL] [Abstract][Full Text] [Related]
59. Evidence based secondary prevention of coronary artery disease in the elderly--2006.
García-Palmieri MR
P R Health Sci J; 2006 Sep; 25(3):229-39. PubMed ID: 17203793
[TBL] [Abstract][Full Text] [Related]
60. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
Okrainec K; Pilote L; Platt R; Eisenberg MJ
Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
